ERBB2 and neoplasm: Based on these studies, assessment of the HR and HER2 status in tumor specimens after NAC is crucial for the definition of the subsequent therapeutic strategies, and therapeutic indications might change when modifications in HR or HER2 status are detected in surgical specimens when compared with diagnostic CNBs.